Collectively, our results suggest that downregulation of HSP70 and subsequent dephosphorylation of G3BP1 sensitize Vemurafenib-resistant melanoma cells to treatment, particularly under additional stress induced by SA. This evidence concerns the gene G3BP1 and melanoma.